Stoke Therapeutics, Inc. — All Filings
571 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001950047-25-009261 | Nov 24, 2025 | — |
| 4 | — | 0001780081-25-000004 | Nov 18, 2025 | Nov 14, 2025 |
| 144 | — | 0001950047-25-008873 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001771015-25-000011 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002853 | Nov 5, 2025 | — |
| 4 | — | 0001780088-25-000004 | Nov 5, 2025 | Nov 3, 2025 |
| 10-Q | 10-Q | 0001193125-25-264720 | Nov 4, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-264644 | Nov 4, 2025 | — |
| 144 | — | 0001950047-25-008382 | Nov 3, 2025 | — |
| SCHEDULE 13G/A | — | 0002012383-25-002708 | Oct 17, 2025 | — |
| 4 | — | 0001197032-25-000004 | Oct 14, 2025 | Oct 8, 2025 |
| 4 | — | 0001522780-25-000007 | Oct 10, 2025 | Oct 8, 2025 |
| 144 | — | 0001950047-25-007849 | Oct 8, 2025 | — |
| 4 | — | 0001522780-25-000004 | Oct 7, 2025 | Oct 3, 2025 |
| 4 | — | 0001966716-25-000004 | Oct 7, 2025 | Oct 3, 2025 |
| 8-K | 8-K | 0001193125-25-230925 | Oct 6, 2025 | Oct 5, 2025 |
| 4 | — | 0001780088-25-000003 | Oct 3, 2025 | Oct 1, 2025 |
| 144 | — | 0001950047-25-007742 | Oct 3, 2025 | — |
| 144 | — | 0001950047-25-007743 | Oct 3, 2025 | — |
| 4 | — | 0001181556-25-000006 | Oct 1, 2025 | Sep 30, 2025 |
| 8-K/A | 8-K/A | 0001193125-25-207401 | Sep 18, 2025 | Jun 3, 2025 |
| 4 | — | 0001415889-25-023792 | Sep 5, 2025 | Sep 4, 2025 |
| 4 | — | 0001415889-25-023591 | Sep 3, 2025 | Sep 2, 2025 |
| 4 | — | 0001415889-25-023589 | Sep 3, 2025 | Aug 29, 2025 |
| 4 | — | 0001415889-25-023590 | Sep 3, 2025 | Aug 29, 2025 |
| 144 | — | 0001950047-25-006649 | Sep 2, 2025 | — |
| 144 | — | 0001950047-25-006555 | Aug 29, 2025 | — |
| 144 | — | 0001950047-25-006558 | Aug 29, 2025 | — |
| SCHEDULE 13D/A | — | 0001123292-25-000387 | Aug 26, 2025 | — |
| 4 | — | 0001415889-25-022442 | Aug 20, 2025 | Aug 18, 2025 |
| 4 | — | 0001415889-25-022441 | Aug 20, 2025 | Aug 18, 2025 |
| 4 | — | 0001415889-25-022440 | Aug 20, 2025 | Aug 18, 2025 |
| 4 | — | 0001415889-25-022225 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0001415889-25-022226 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0001415889-25-022227 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0001415889-25-022074 | Aug 15, 2025 | Aug 13, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-078641 | Aug 14, 2025 | — |
| 144 | — | 0001950047-25-005776 | Aug 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-107332 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-107275 | Aug 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-177433 | Aug 11, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002118 | Aug 6, 2025 | — |
| 4 | — | 0001415889-25-021024 | Aug 5, 2025 | Aug 1, 2025 |
| SCHEDULE 13G/A | — | 0001085146-25-004276 | Jul 29, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-002218 | Jul 15, 2025 | — |
| EFFECT | — | 9999999995-25-002242 | Jul 11, 2025 | — |
| 8-K | 8-K | 0001193125-25-157364 | Jul 10, 2025 | — |
| S-3 | S-3 | 0001193125-25-157072 | Jul 9, 2025 | — |
| S-8 | S-8 | 0001193125-25-157079 | Jul 9, 2025 | — |
| CORRESP | — | 0001193125-25-157116 | Jul 9, 2025 | — |